Topics covered: Third tier and rural markets, The spending gap, The local advertising environment, The intellectual property front, The 2.5Ghz Spectrum, The "All-Digital" Move, Radio consolidation, On-Demand advertisement, Implementing the Syndication model, Growth in non-traditional revenue, Driving margin expansion
Topics covered: The top-down, Diversification and risk control
Topics covered: The FDA Clamp-Down, The changing Pharmaceutical Business Model, Targeted Therapies in Oncology, Supplying unmet medical needs, Stem cell preservation, Phase III Trials, Pharmaceutical and Biotech partnerships, Oncology and Acute care, New uses for stalled drugs, Intracellular Signaling Pathways, Growing new blood vessels, Antisense Technology
Topics covered: Video Games, Therapeutic indications, The tanker segment, The LPG market, The dry bulk segment, The antiviral space, Sluggish semi cap momentum, RNAi and antisense technology, Obesity, Metabolic disease, Memory spending, Inventory levels, Inflammation and pain, Healthcare information technology, DRAM growth, Combination compounds, CNS disease indications, Anti-aging categories, Aesthetic laser companies
Topics covered: Volatility, Small and mid-cap investing, Sell rules to protect capital, Robust growth relative to large cap companies, Not incurring large losses, Mutual funds, Mid-cap management teams, Laddered bond strategy, GARP investing, Diversified asset allocation, Computer screening, Analysis of investment professionals
